The FDA announced the approval of inavolisib (Itovebi, Genentech, Inc.) to be used in patients who have locally advanced or metastatic breast cancer that is endocrine resistant, PIK3CA-mutated, hormone receptor (HR)-positive, and HER2-negative. The treatment can be given after recurrence […]
FDA Approves Inavolisib in Locally Advanced, Metastatic Breast Cancer Read More »
The cost-effectiveness of trifluridine/tipiracil (TAS-102) plus bevacizumab, used in the treatment of colorectal cancer (CRC), varies across multiple countries, according to a study published in Therapeutic Advances in Gastroenterology.1 The study compared cost effectiveness of the third line treatment in
Cost Effectiveness Varies in TAS-102 Plus Bevacizumab Third Line Treatment Read More »
New data from the phase 3 PURPOSE 2 trial (NCT04925752) were presented at the 5th HIV Research for Prevention Conference held in Lima, Peru, that could indicate significant efficacy of lenacapavir in preventing HIV. Early results show a 96% rate
Lenacapavir Highly Effective in Preventing HIV Read More »
During an interview on the show, The View, Vice President Kamala Harris announced that, should she win the presidential election on November 6, she would aim to expand Medicare such that the government insurance primarily aimed at retired adults would
Expansion of Medicare Home Care Coverage on the Table With Harris Announcement Read More »
A new study published in Ageing Research Reviews1 found an association between eye disease and dementia, along with dementia subtypes. The association, found in studies with weaker evidence, should encourage future studies into the area. Cognitive impairment and dementia affect
Evidence Suggests Association Between Eye Disease, Dementia Read More »
Virologic suppression was maintained in Black patients with HIV who switched to bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) after they had achieved virologic suppression for 48 weeks, according to the results of a phase 3b study published in the Journal of Medical Virology.1
The US Preventive Services Task Force’s (USPSTF) recommendations for screening for colorectal cancer (CRC) have had an immediate effect on testing rates in patients aged 45 to 49 years, according to a study published in JAMA Network Open.1 Screening in
CRC Screening Increases in Patients Aged 45 to 49 After USPSTF Recommendation Read More »
Adults aged 76 to 85 years were more likely to continue testing for colorectal cancer (CRC) due to medical maximizing or anticipated decision regret, with more adults expressing visitor satisfaction after discussing testing. The study published in Patient Education and
Treatment for HIV/AIDS has consistently seen progress each decade, since the virus first appeared, as new information about the virus has been discovered and implemented in medical practice. In honor of AIDS Awareness Month, this article will take a trip
5 Decades of Notable Achievements in Treatment for HIV/AIDS Read More »
Data from 2022 reveal that 1 or 2 health systems were responsible for the entire market in nearly half of the metropolitan areas in the US, which can affect the price and quality of inpatient care in these areas, according
Metropolitan Areas Dominated by 1 or 2 Health Systems in 2022 Read More »
